• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

TGF expands medical advisory board


The Glaucoma Foundation announced the addition of four new members to its medical advisory board.

The Glaucoma Foundation (TGF) announced the addition of four new members to its medical advisory board. Board members keep the foundation informed of all medical advances to ensure that educational, informational, and outreach programs are current, accurate, and responsive to patient needs.

The new members are:

  • Balwantray Chauhan, PhD, professor and research director of ophthalmology and visual sciences and professor of physiology and biophysics at Dalhousie University, Halifax, Nova Scotia. Dr. Chauhan is the principal investigator of the Canadian Glaucoma Study.

  • Philip P. Chen, MD, associate professor in the Department of Ophthalmology at the University of Washington in Seattle. His research interests include diagnosis, treatment methods (medical and surgical), and outcomes of treatment of open-angle and angle-closure glaucoma, and anterior segment surgery.

  • David S. Greenfield, MD, professor of ophthalmology at the Bascom Palmer Eye Institute, University of Miami School of Medicine. His research interests include optic disc and retinal nerve fiber imaging in glaucoma, bleb-related ocular infection, normal-tension glaucoma, and complex glaucoma filtration surgery.

  • David S. Walton, MD, clinical professor of ophthalmology at Harvard Medical School, Boston, and is board certified in both pediatrics and ophthalmology. His research interests focus on the mechanisms of childhood glaucoma.

TGF is dedicated to funding groundbreaking research and educating the public about glaucoma and the importance of early detection to prevent blindness.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.